Investigating how tumor surroundings affect cancer cell growth in pancreatic cancer

Targeting Stromal Influences on BCKA Addiction in PDAC Tumors

NIH-funded research University of Michigan at Ann Arbor · NIH-11080963

This study is looking at how certain cells in the environment around pancreatic cancer cells affect the way the cancer uses important nutrients, with the hope of finding new ways to improve treatment for people with this type of cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor NIH-funded
Lab location1 site (Ann Arbor, United States)
Project IDNIH-11080963 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the tumor microenvironment, particularly the cancer-associated fibroblasts (CAFs), in pancreatic ductal adenocarcinoma (PDAC). It aims to explore how these stromal cells influence the metabolism of branched chain amino acids (BCAAs) and their impact on cancer progression. By examining the metabolic interactions between cancer cells and stromal cells, the research seeks to identify potential therapeutic targets that could improve treatment outcomes for patients with PDAC. The study will utilize patient-derived samples to validate findings and explore new treatment strategies.

Who could benefit from this research

Good fit: Ideal candidates for this research are patients diagnosed with pancreatic ductal adenocarcinoma, particularly those with specific genetic alterations such as SMAD4 deletion.

Not a fit: Patients with other types of cancer or those without pancreatic ductal adenocarcinoma may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that specifically target the metabolic interactions in pancreatic cancer, potentially improving survival rates.

How similar studies have performed: Other research has shown promising results in targeting metabolic pathways in cancer, suggesting that this approach could be effective, although the specific focus on stromal influences in PDAC is relatively novel.

Where this research is happening

Ann Arbor, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions addictive disorderanti-cancer therapycancer cell
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.